Evaluating the efficacy of rimegepant as a preventive treatment for chronic and episodic migraine: a three-month longitudinal retrospective cohort study

• by Hamza Khan, Muhammad Saqib Khan, Sheraz Khan, Fang Liu, Quan Feng, Irfan Ahmad, Ge Tan

• June 4, 2026

Zack Z. Ramilevich, M.D., Joins Marcus Neuroscience Institute as a General Neurologist

Board-certified neurologist Zack Z. Ramilevich, M.D., has joined Marcus Neuroscience Institute, part of Baptist Health, as a general neurologist.

• March 26, 2026

• 2 min

Floaters May Signal Higher Risk Than Flashes

New study examines retinal detachment risk in primary care presentations

• by Conexiant News Staff

• March 24, 2026

• 3 min

Evaluating the Efficacy and Safety of Preventive Therapies for Vestibular Migraine: A Systematic Review and Network Meta-Analysis

• by Sindhu Vasireddy, Shankar Biswas, Raja Kollu, Elangovan Krishnan, Mohammed Semaal Khan, Fasil C, Arjun Jayakumar, Reena Acharya

• December 30, 2025